M logo

Med Life S.A. Stock Price

BVB:M Community·RON 6.5b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 30 Fair Values set on narratives written by author

M Share Price Performance

RON 12.16
5.46 (81.49%)
RON 9.97
Fair Value
RON 12.16
5.46 (81.49%)
22.0% overvalued intrinsic discount
RON 9.97
Fair Value
Price RON 12.16
AnalystConsensusTarget RON 9.97
AnalystLowTarget RON 7.10
AnalystHighTarget RON 12.50

M Community Narratives

·
Fair Value RON 9.97 22.0% overvalued intrinsic discount

Future Expansion Into Complex Services Will Strain Margins And Limit Earnings Potential

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value RON 7.1 71.3% overvalued intrinsic discount

Genomics Expansion And Rising CapEx Will Pressure Margins And Future Earnings

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value RON 12.5 2.7% undervalued intrinsic discount

High-Complexity Healthcare Expansion And Digitalization Will Support Long-Term Earnings Potential

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
RON 7.1
71.3% overvalued intrinsic discount
Revenue
11.11% p.a.
Profit Margin
7.58%
Future PE
15.97x
Price in 2029
RON 10.16
RON 9.97
22.0% overvalued intrinsic discount
Revenue
10.41% p.a.
Profit Margin
6.2%
Future PE
28.46x
Price in 2029
RON 14.21

Trending Discussion

Updated Narratives

M logo

M: Fairly Priced Outlook Will Rely On Steady Margins And P/E Assumptions

Fair Value: RON 12.5 2.7% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
M logo

Genomics Expansion And Rising CapEx Will Pressure Margins And Future Earnings

Fair Value: RON 7.1 71.3% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
M logo

Future Expansion Into Complex Services Will Strain Margins And Limit Earnings Potential

Fair Value: RON 9.97 22.0% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

High growth potential and slightly overvalued.

2 Risks
2 Rewards

Med Life S.A. Key Details

RON 3.2b

Revenue

RON 1.7b

Cost of Revenue

RON 1.6b

Gross Profit

RON 1.6b

Other Expenses

RON 7.7m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 28, 2026
0.014
48.48%
0.24%
272.9%
View Full Analysis

About M

Founded
1996
Employees
6744
CEO
Mihail Marcu
WebsiteView website
www.medlife.ro

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.

Med Life S.A. Competitors